These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 1686579

  • 1. Antihypertensive therapy and mobilization of renal functional reserve.
    Burnier M, Biollaz J, Steinhauslin F, Brouard R, Waeber B, Brunner HR.
    Clin Invest Med; 1991 Dec; 14(6):581-9. PubMed ID: 1686579
    [Abstract] [Full Text] [Related]

  • 2. Nephroprotection by antihypertensive agents.
    Schmieder RE.
    J Cardiovasc Pharmacol; 1994 Dec; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [Abstract] [Full Text] [Related]

  • 3. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH, Reams GP.
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [Abstract] [Full Text] [Related]

  • 4. Renal reserve in patients with high blood pressure.
    Gabbai FB.
    Semin Nephrol; 1995 Sep; 15(5):482-7. PubMed ID: 8525152
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Are all antihypertensive drugs renoprotective?].
    Wolf S, Risler T.
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [Abstract] [Full Text] [Related]

  • 7. Antihypertensive drugs in renal failure.
    Albert FW.
    J Cardiovasc Pharmacol; 1994 May; 24 Suppl 2():S108-12. PubMed ID: 7898089
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effects of antihypertensive therapy on renal function.
    Rappelli A, Baldinelli A, Zingaretti O, Espinosa E, Salvi S, Fulgheri PD.
    J Hypertens Suppl; 1991 Dec; 9(3):S37-40. PubMed ID: 1686783
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
    Minutolo R, Gabbai FB, Borrelli S, Scigliano R, Trucillo P, Baldanza D, Laurino S, Mascia S, Conte G, De Nicola L.
    Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
    [Abstract] [Full Text] [Related]

  • 12. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
    Bailey RR, Shand BI, Smith AH, Robson RA, Lynn KL.
    Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Drug therapy for hypertension in hemodialysis patients.
    Hörl MP, Tepel M.
    Minerva Med; 2005 Aug; 96(4):277-85. PubMed ID: 16179894
    [Abstract] [Full Text] [Related]

  • 15. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R, Poliak R, Stiasny B, Schmieder RE, Schulze BD.
    Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
    [Abstract] [Full Text] [Related]

  • 16. [The influence of antihypertensive treatment on progression of chronic nepropathy].
    Petersen LJ, Ladefoged SD, Jensen HA.
    Ugeskr Laeger; 1997 Jul 28; 159(31):4745-51. PubMed ID: 9265325
    [Abstract] [Full Text] [Related]

  • 17. Long-term effects of antihypertensive agents on proteinuria and renal function.
    Maki DD, Ma JZ, Louis TA, Kasiske BL.
    Arch Intern Med; 1995 May 22; 155(10):1073-80. PubMed ID: 7748051
    [Abstract] [Full Text] [Related]

  • 18. Renal haemodynamic and protective effects of calcium antagonists in hypertension.
    Zanchi A, Brunner HR, Waeber B, Burnier M.
    J Hypertens; 1995 Dec 22; 13(12 Pt 1):1363-75. PubMed ID: 8866898
    [Abstract] [Full Text] [Related]

  • 19. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L, Kocks MJ, Laverman GD, Navis G.
    Minerva Med; 2004 Oct 22; 95(5):395-409. PubMed ID: 15467515
    [Abstract] [Full Text] [Related]

  • 20. Treatment of hypertension in chronic kidney disease.
    Toto RD.
    Semin Nephrol; 2005 Nov 22; 25(6):435-9. PubMed ID: 16298269
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.